HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.14
Day range
$0.14 - $0.15
Year range
$0.010 - $0.19
Market cap
6.19M CAD
Avg Volume
39.70K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 227.76K | 3.81% |
Net income | -232.81K | 0.08% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 577.67K | 93.64% |
Total assets | 711.16K | 11.26% |
Total liabilities | 3.17M | 407.08% |
Total equity | -2.45M | — |
Shares outstanding | 39.79M | — |
Price to book | -2.42 | — |
Return on assets | -99.38% | — |
Return on capital | 52.16% | — |
Cash Flow
Net change in cash
(CAD) | Jan 2024info | Y/Y change |
---|---|---|
Net income | -232.81K | 0.08% |
Cash from operations | -239.31K | -0.72% |
Cash from investing | — | — |
Cash from financing | 500.00K | — |
Net change in cash | 260.69K | 209.72% |
Free cash flow | -162.88K | -10.12% |
About
Founded
2021
Headquarters
Website